Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selegiline Transdermal System for Cocaine Dependence
NCT00032929Phase 3Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Mar 2001
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of selegiline in cocaine dependence, sponsored by National Institute on Drug Abuse. Started Mar 2001; status: completed.
02
Drugs
selegiline
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00032929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032929.